Treatment with Gd-DTPA or GDD significantly increased TRPC5 expression and decreased the accumulation of ADM in the nuclei of MCF-7 and SK-BR-3 cells, increasing the risk ofchemoresistance in the breast cancer cells. The gene discussed is TRPC5; the disease is breast cancer.